Finance

Lists
002294:SHE
Shenzhen Salubris Pharmaceuticals Co Ltd
30,84 CN¥
+0,85%
(+0,26) 1D
16-окт., 15:04:54 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002294...
Open
30,83 CN¥
High
31,80 CN¥
Low
30,82 CN¥
Mkt. cap
33,85 млд
Avg. vol.
9,55 млн
Volume
27,91 млн
Dividend
1,78%
Quarterly dividend
0,14 CN¥
Ex-dividend date
2026-ж., 26-май
P/E ratio
51,05
52-wk high
70,99 CN¥
52-wk low
29,25 CN¥
EPS
0,60 CN¥
Shares outstanding
1,11 млд
No. of employees
4 миң
Open
30,83 CN¥
High
31,80 CN¥
Low
30,82 CN¥
Mkt. cap
33,85 млд
Avg. vol.
9,55 млн
Volume
27,91 млн
Dividend
1,78%
Quarterly dividend
0,14 CN¥
Ex-dividend date
2026-ж., 26-май
P/E ratio
51,05
52-wk high
70,99 CN¥
52-wk low
29,25 CN¥
EPS
0,60 CN¥
Shares outstanding
1,11 млд
No. of employees
4 миң
News stories
From web sources and news partners
Profile
Shenzhen Salubris Pharmaceuticals is a Chinese pharmaceutical company. Founded in November 1998 and based in Shenzhen, it has a market cap of US$4.4 billion, 3,121 employees and annual sales of $553 million as of 2019. Shenzhen Salubris is headed by the billionaire Ye Chenghai. Wikipedia
About Shenzhen Salubris Pharmaceuticals Co Ltd
CEO-
Employees4,09 миң
Founded1998-ж., 3-ноя.
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
1,11 млд
1,11 млд
1,23 млд
1,25 млд
Cost of goods sold
279,29 млн
302,88 млн
287,67 млн
343,20 млн
Cost of revenue
279,29 млн
302,88 млн
287,67 млн
343,20 млн
Research and development expenses
127,63 млн
176,44 млн
131,32 млн
139,63 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
486,77 млн
568,30 млн
551,61 млн
596,71 млн
Operating expense
595,66 млн
770,11 млн
694,36 млн
749,18 млн
Total operating expenses
874,96 млн
1,07 млд
982,03 млн
1,09 млд
Operating income
235,37 млн
38,38 млн
246,41 млн
158,32 млн
Other non operating income
-14,62 млн
13,83 млн
-5,27 млн
5,40 млн
EBT including unusual items
234,09 млн
5,21 млн
255,47 млн
142,37 млн
EBT excluding unusual items
246,15 млн
72,00 млн
252,02 млн
160,96 млн
Income tax expense
18,06 млн
-56,18 млн
29,65 млн
-22,28 млн
Effective tax rate
7,72%
-1 078,48%
11,60%
-15,65%
Other operating expenses
-17,83 млн
34,11 млн
9,61 млн
16,33 млн
Net income
215,63 млн
70,80 млн
225,27 млн
161,82 млн
Net profit margin
19,42%
6,37%
18,34%
12,94%
Earnings per share
-
-
-
-
Interest and investment income
26,87 млн
37,76 млн
15,05 млн
12,29 млн
Interest expense
-4,88 млн
-7,50 млн
-4,17 млн
-4,97 млн
Net interest expenses
22,00 млн
30,27 млн
10,88 млн
7,32 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
325,52 млн
135,48 млн
343,52 млн
257,90 млн
Gain or loss from assets sale
-983,77 миң
3,03 млн
-
166,24 миң
AI content may include mistakes. Learn more
Google колдонмолору